Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Ceretas Ltd

CTS.AX ✓ COMPLIANTFree checks used up today ☆ Track — members

ASX · Healthcare · Pharmaceuticals ·

Australia N/A Analyst: N/A

Last Close

$0.70

▲ +0.00%

Market Cap N/A · Vol 8.00K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

N/A

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

45.52

Momentum

Beta

N/A

vs Market

52W High

$0.79

11.86% below

52W Low

$0.31

135.19% above

Volume

8.00K

Avg 135.82K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

58.46%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Ceretas Ltd (CTS.AX) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CTS.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.51%

+20.73%

N/A

YTD

N/A

Financials & Valuation

TTM · Annual

Total Revenue	N/A
Net Income	N/A
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	N/A · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	48.42M

Technical Indicators

50-Day SMA	$N/A
200-Day SMA	$N/A
RSI (14)	45.52
Beta	N/A
52-Week High	$0.79
52-Week Low	$0.31

Volume Today	8.00K
Avg Daily Volume (30D)	135.82K
Relative Volume	0.06x
Volatility (10D)	95.87
Volatility (30D)	85.21
Free Float	58.46%

Analyst Consensus

N/A

Current Price $0.70

Mean Target N/A

52W Low$0.31 52W High$0.79

Current

Target

$0.31 $0.79

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIN/A

ISINAU0000475766

CountryAustralia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Company +1.04% JNJ Johnson & Johnson -0.19% ABBV AbbVie Inc. +0.20% NVS Novartis AG +0.43% NOVN.S Novartis AG +0.90%

Company Profile

Ceretas Limited is an Australia-based medical technology company. The Company is engaged in developing a portable, non-invasive therapeutic ultrasound platform for the treatment of Alzheimer's disease and other neurodegenerative conditions (Ceretas Device). The Company's initial clinical focus is neuromodulation, which uses low-intensity focused ultrasound to stimulate neural circuits involved in memory, cognition and mood. The Ceretas Device is a therapeutic ultrasound platform that delivers low-intensity focused ultrasound non-invasively through the skull to targeted regions of the brain. The system integrates three core components: a focused ultrasound transducer and signal chain that generates and delivers the acoustic energy; a fluid coupling system that ensures efficient transmission of ultrasound from the transducer to the scalp, and an image-guided neuronavigational system which directs the transducer to precise brain targets based on each patient’s individual MRI scan.